TY - JOUR
T1 - A 'year in the life' of health services research in oncology.
AU - Brundage, Michael D.
AU - Snyder, Claire F.
AU - Bass, Brenda
N1 - Funding Information:
CF Snyder is funded by a Mentored Research Scholar Grant from the American Cancer Society (MRSG-08-011-01-CPPB). MD Brundage is supported in part by a research chair award from Cancer Care Ontario, Canada. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
PY - 2012/10
Y1 - 2012/10
N2 - Oncology health services research (HSR) is a broad, multidimensional field. Current areas of research foci may be informative. We searched Medline for oncology HSR papers published in English in a single year (2009). Abstracted data related to access, quality, cost, health/wellbeing, place on the cancer continuum and study design. Among 1113 papers, the most commonly studied HSR domain was quality-of-care (65%). Within the care continuum, 'treatment' received the greatest attention (37%), and 'prevention' the least (5%). More specifically, treatment-related quality-of-care was most often studied (23%). Breast cancer was the most common site focus (28%). Most studies were descriptive (75%), retrospective (35%) or cross-sectional (35%). These findings might inform the decisions of researchers or policy makers seeking to improve cancer health services delivery.
AB - Oncology health services research (HSR) is a broad, multidimensional field. Current areas of research foci may be informative. We searched Medline for oncology HSR papers published in English in a single year (2009). Abstracted data related to access, quality, cost, health/wellbeing, place on the cancer continuum and study design. Among 1113 papers, the most commonly studied HSR domain was quality-of-care (65%). Within the care continuum, 'treatment' received the greatest attention (37%), and 'prevention' the least (5%). More specifically, treatment-related quality-of-care was most often studied (23%). Breast cancer was the most common site focus (28%). Most studies were descriptive (75%), retrospective (35%) or cross-sectional (35%). These findings might inform the decisions of researchers or policy makers seeking to improve cancer health services delivery.
UR - http://www.scopus.com/inward/record.url?scp=84877156995&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84877156995&partnerID=8YFLogxK
U2 - 10.1586/erp.12.50
DO - 10.1586/erp.12.50
M3 - Review article
C2 - 23186402
AN - SCOPUS:84877156995
SN - 1473-7167
VL - 12
SP - 615
EP - 622
JO - Expert review of pharmacoeconomics & outcomes research
JF - Expert review of pharmacoeconomics & outcomes research
IS - 5
ER -